MedTrace Logo

The Effect of Nebivolol on Insulin Sensitivity

NCT00125853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2019-12-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to conduct a randomised trial to compare the insulin sensitivity, 24 hour blood pressure profile, and tolerability of nebivolol plus a thiazide-like diuretic versus atenolol plus a thiazide-like diuretic.

Conditions

Interventions

DRUG

Nebivolol

Nebivolol 2.5mg daily

DRUG

Atenolol

Atenolol 25mg daily

Sponsors & Collaborators

  • Foundation for Circulatory Health

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Neil R Poulter · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00125853 on ClinicalTrials.gov